ScholarLens Back to search
1991•PubMedRequires access

[Transrectal hyperthermia for benign prostatic hyperplasia].

Yasuo Satoh, Kiyoki Okada

Open publisher page 0 citations

Abstract

The PRIMUS system was designed as a dedicated microwave hyperthermia system for treatment of benign prostatic hyperplasia (BPH). Completed cases were 36 patients. Hyperthermia was subjectively effective in 31 patients (86%), but no appreciable changes were noted with regard to the size of the prostate. Side effects occurred in 10 of the evaluable 49 cases (20%). However, no severe side effects were recognized except in one case. The effective ratio revealed 25 of 36 cases (69%). Therefore, transrectal prostatic hyperthermia would be a useful method especially in cases of BPH with severe complications.

About this research paper

What this paper is about

The PRIMUS system was designed as a dedicated microwave hyperthermia system for treatment of benign prostatic hyperplasia (BPH). Completed cases were 36 patients. Hyperthermia was subjectively effective in 31 patients (86%), but no appreciable changes were noted with regard to the size of the prostate. Side effects occurred in 10 of the evaluable 49 cases (20%). However, no severe side effects were recognized except in one case. The effective ratio revealed 25 of 36 cases (69%). Therefore, transrectal prostatic hyperthermia would be a useful method especially in cases of BPH with severe complications.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The PRIMUS system was designed as a dedicated microwave hyperthermia system for treatment of benign prostatic hyperplasia (BPH). Completed cases were 36 patients. Hyperthermia was subjectively effective in 31 patients (86%), but no appreciable changes were noted with regard to the size of the prostate. Side effects occurred in 10 of the evaluable 49 cases (20%). However, no severe side effects were recognized except in one case. The effective ratio revealed 25 of 36 cases (69%). Therefore, transrectal prostatic hyperthermia would be a useful method especially in cases of BPH with severe complications.

Key concepts: Hyperthermia, Hyperplasia, Medicine, Urology, Prostate, Internal medicine, Cancer

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
[Transrectal hyperthermia for benign prostatic hyperplasia]. — Research Paper | ScholarLens